INmune Bio Inc. (INMB)

AI Score

Unlock

7.88

-0.16 (-1.99%)

At close: Apr 25, 2025, 9:59 AM

INmune Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016
Net Income	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.56M	-6.5M	-6.54M	-5.83M	-7.72M	-6.84M	-6.9M	-9.67M	-9.46M	-6.66M	-4.56M	-3.2M	-4.72M	-2.11M	-2.07M	-2.32M	-3.07M	-392.08K	-1.9M	-1.88M	-1.54M	-6.17M	-2.85M	-428.24K	-307.53K	-165.13K	30.55K	-134.68K	-54.2K
Depreciation & Amortization	n/a	-24K	24K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.76M	1.72M	2.35M	1.78M	1.88M	1.89M	1.86M	1.74M	1.79M	1.94M	1.89M	1.54M	1.52M	1.61M	769K	899K	702.94K	1.05M	681.71K	681.71K	1.17M	974.7K	974.7K	974.7K	954.82K	979.56K	5.61M	2.46M	162.63K	n/a	36.92K	n/a	n/a	n/a
Other Working Capital	512K	-4.44M	138K	570K	-7.12M	996K	1.1M	6.72M	-3.46M	495K	1M	-2.3M	-1.27M	-1.99M	-627K	-1.47M	-242.92K	-378.6K	-442.01K	31.6K	519.66K	155.27K	-685.68K	-118.45K	-149.59K	94.26K	-248.51K	169.47K	-257.94K	178.74K	-12.32K	-127.29K	-99.3K	n/a
Other Non-Cash Items	6K	4.63M	3.03M	647K	45K	54K	58K	67K	68K	147K	57K	56K	57K	53K	16K	1.41M	353K	351K	48K	323K	192.74K	-8.76K	-1.54M	-42.91K	612.34K	16.1K	4.53K	-113.35K	148.18K	-25.84K	52.71K	-47.29K	-13.57K	54.2K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.56M	-1.22M	-514K	1.74M	3.08M	2.36M	1.41M	3.59M	-1.72M	2.27M	136K	-3.55M	-1.69M	-124K	161K	-1.44M	108.64K	-26.83K	-392.1K	353.81K	712.4K	146.51K	-658.44K	-461.36K	462.74K	110.36K	-249.54K	56.11K	-109.76K	178.74K	-12.32K	-127.29K	-99.3K	n/a
Operating Cash Flow	-11.01M	-6.99M	-7.89M	-7.48M	-3.4M	-4.26M	-3.17M	-1.14M	-5.7M	-3.37M	-4.76M	-8.87M	-9.78M	-7.92M	-5.71M	-5.09M	-2.39M	-3.7M	-1.82M	-1.03M	-433.37K	-1.95M	-1.62M	-1.39M	-462.38K	-449.93K	-817.85K	-328.84K	-375.36K	-154.63K	-87.81K	-144.03K	-247.54K	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	2.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15M	n/a	-15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-100K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	2.55M	-2.55M	n/a	n/a	699K	n/a	-699K	n/a	-15M	n/a	-15M	n/a	-23.87B	n/a	n/a	n/a	-12.2B	n/a	n/a	n/a	-899.1M	n/a	n/a	n/a	-100K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-2.5M	-2.5M	-2.5M	-2.5M	-2.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.01M	n/a	n/a	-1.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	422K	n/a	15.5M	n/a	n/a	-2.5M	n/a	n/a	n/a	n/a	n/a	30K	80.25M	1.14M	14.95M	18K	23.9B	n/a	n/a	356.00	12.2B	n/a	n/a	n/a	899.1M	n/a	n/a	n/a	n/a	30K	1.66M	371K	100K	n/a
Financial Cash Flow	-2.08M	9.79M	13M	-2.5M	-2.5M	-1.73M	n/a	n/a	-699K	n/a	n/a	729K	n/a	52.94M	14.95M	28.46M	23.87B	23.24M	664K	-9K	12.2B	n/a	4.96M	7.25M	899.1M	n/a	n/a	900K	n/a	30K	1.66M	371K	100K	n/a
Net Cash Flow	-12.63M	2.48M	5.07M	-9.85M	-5.96M	-6.01M	-3.18M	-1.15M	-5.25M	-3.81M	-5.52M	-8.08M	-9.66M	44.95M	-5.82M	23.37M	-2.34M	19.49M	-1.11M	-1.06M	-387.14K	-1.98M	3.32M	5.86M	-464.66K	-457.55K	-847.89K	585.59K	-472.79K	-108.84K	1.58M	231.41K	-153.78K	n/a
Free Cash Flow	-11.01M	-6.99M	-7.89M	-7.48M	-3.4M	-4.26M	-3.17M	-1.14M	-5.7M	-3.37M	-4.76M	-8.87M	-9.78M	-7.92M	-20.71M	-5.09M	-2.39M	-3.7M	-1.82M	-1.03M	-433.37K	-1.95M	-1.62M	-1.39M	-462.38K	-449.93K	-817.85K	-328.84K	-375.36K	-154.63K	-87.81K	-144.03K	-247.54K	n/a